Psoriasis


Psoriasis is a skin condition estimated to affect about 2-4% of the world population. The most common form is psoriasis vulgaris (plaque-type psoriasis) which is characterized by lesions which often itch and burn and manifest as raised, inflamed, red skin covered with silvery, white scales. The disease can appear anywhere although it is most common on the elbows and knees, plus the scalp and lower back.

You or someone you know with Psoriasis may qualify for an FDA-registered clinical trial of a novel investigational drug from a major pharmaceutical company.

Psoriasis2019-06-13T20:22:32+00:00

Project Description

About Psoriasis

Psoriasis is a skin condition estimated to affect about 2-4% of the world population.  The most common form is psoriasis vulgaris (plaque-type psoriasis) which is characterized by lesions which often itch and burn and manifest as raised, inflamed, red skin covered with silvery, white scales.  The disease can appear anywhere although it is most common on the elbows and knees, plus the scalp and lower back.

  • All study volunteers are given written informed consent

  • Patient volunteers are never charged a fee for participating in or medications used in any of our clinical trials

  • Clinical study volunteers receive compensation for their time and travel

  • All clinical trials are reviewed and approved by licensed Investigational Review Boards for ethics and patient safety

  • All of our clinical trials are referenced in a national base: clintrials.gov

  Requirements For Participation

AGES18+ yrs.
Disease SeverityModerate to Severe Plaque type for at least 6 months
Body Surface Involved> 10 %
Visits Required15-21

  For More Information

   LOCATION

Contact Us About Enrolling

To see if you qualify for a clinical trial and want to learn more, please fill out this form and we will get back to you!